Control cells stimulated with S100A4 and PAH‐PASMCs had a 3‐fold decrease in PPARγ expression (percentage of cells with PPARγ activated of total cells measured by DAPI). This evidence concerns the gene PPARG and pulmonary arterial hypertension.